Home › Funds › Contrarius Group Holdings Ltd › BEAM

Contrarius Group Holdings Ltd position in BEAM

BEAM THERAPEUTICS INC · Health Care

Contrarius Group Holdings Ltd reported holding 522,461 shares of BEAM (BEAM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$12.8M, representing 0.62% of its reported portfolio and ranking #22 among its reported holdings. Contrarius Group Holdings Ltd has disclosed BEAM holdings in 5 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)522.46K sh
Reported value held$12.77M
Portfolio Weight0.62%
First reportedQ1 2025
Last changeReduce
Updated2026-11-10

Last updated: 2026-11-10 · Source: SEC EDGAR Form 13F-HR

How Contrarius Group Holdings Ltd's BEAM position evolved

Contrarius Group Holdings Ltd first disclosed a stake in BEAM in Q1 2025 at 126,470 shares (US$2.5M). The position peaked in Q2 2026 at 1,614,538 shares, worth US$55.4M. Across 5 filings, Contrarius Group Holdings Ltd increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 522,461 shares valued at US$12.8M — a reduction of -1,092,077 shares quarter over quarter.. Notable position changes include a 203% increase in Q2 2026 (shares fell 32% over the following quarter), a 68% trim in Q3 2026 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 126.47K $2.47M New
Q3 2025 1.53M $37.21M New
Q1 2026 533.44K $12.71M New
Q2 2026 1.61M $55.41M Add
Q3 2026 522.46K $12.77M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BEAM and 13F data

BEAM (BEAM THERAPEUTICS INC) is a Health Care company. 34 other funds we track also report a position in BEAM — the largest reported positions include Farallon Capital Management (US$351.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$351.3M), ARK Invest (US$351.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BEAM

All BEAM fund holders →

FAQ

How long has Contrarius Group Holdings Ltd held BEAM?

Contrarius Group Holdings Ltd has disclosed BEAM holdings in 5 of the last 7 reported quarters, going back to Q1 2025.

What is Contrarius Group Holdings Ltd's current position in BEAM?

As of Q3 2026, Contrarius Group Holdings Ltd holds 522.46K shares of BEAM (BEAM THERAPEUTICS INC), valued at $12.77M, representing 0.62% of its reported portfolio and ranking #22.

Has Contrarius Group Holdings Ltd been buying or selling BEAM?

In the latest 13F filing (Q3 2026), Contrarius Group Holdings Ltd reduced its position in BEAM. The position peaked in Q2 2026 at 1.61M shares.

Which other funds hold BEAM?

Other major institutional holders of BEAM include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., ARK Invest, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.